Modern glaucoma care is all about the patient, according to a speaker at the American Glaucoma Society meeting.
Andrew G. Iwach, MD, said specialists look at metrics such as IOP, number of medications and visual field change to determine the success of a patient’s glaucoma treatment. However, patients perceive success in a different way.
“The FDA is trying to look at different metrics, particularly with MIGS, because IOP doesn’t fully capture their benefit,” he said during the Glaucoma Surgery Day Lecture. “The real voice in all this is the patient. (Read more...)